EP Patent

EP2216017A1 — Mucosal bioadhesive slow release carrier for delivering active principles

Assigned to Bioalliance Pharma SA · Expires 2010-08-11 · 16y expired

What this patent protects

A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at l…

USPTO Abstract

A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer and at least one sustained release polymer, as well as a method for its preparation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2216017A1
Jurisdiction
EP
Classification
—
Expires
2010-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Bioalliance Pharma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.